ProUroCare Medical Documenten
Documenten
100
Ticker
PUMD
ISIN
US74373C2061
ProUroCare Medical SEC Filings
ProUroCare Medical Documenten 2026
Deze pagina bevat alle officiële documenten en SEC-filings voor ProUroCare Medical aandelen (PUMD, ISIN: US74373C2061). Dit omvat jaarverslagen (Formulier 10-K), kwartaalrapporten (Formulier 10-Q) en insidertransacties (Formulier 4). Momenteel zijn 100 documenten beschikbaar. Gegevens worden regelmatig bijgewerkt om beleggers een volledig overzicht van ProUroCare Medical's regelgevingsfilings te bieden.
ProUroCare Medical Aandelenanalyse
ProUroCare Medical ProUroCare Medical Inc, based in Eden Prairie, US, develops medical devices for prostate disease detection and characterization. The company focuses on the ProUroScan System, an imaging device that creates real-time elasticity images of the prostate using a rectal probe and specialized software. This system aids in visualizing abnormalities detected during digital rectal exams, offering two- and three-dimensional imaging capabilities. With a small team of two employees, ProUroCare operates in the Health Care sector, specializing in diagnostic tools for prostate health.